Mitochondrial-based Determinants of Sex Differences in Acute Kidney Injury

急性肾损伤性别差异的线粒体决定因素

基本信息

  • 批准号:
    10274740
  • 负责人:
  • 金额:
    $ 22.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-15 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Acute kidney injury (AKI) afflicts substantial numbers of hospitalized patients, particularly those who are critically ill. Because protection from AKI in females is observed both clinically and in animal models, a better elucidation of the underlying biology of this protection may be essential to providing novel, effective intervention to both females and males with AKI. In support of a sex-based susceptibility to AKI, we have shown that female mice undergoing cisplatin-induced AKI (CP) have preserved renal function compared to males, which have significantly worse AKI. Clarity in the mechanisms that underpin resistance of females to renal injury has the potential to illuminate unique pathological mechanisms and represents a critical gap in our knowledge. Mitochondrial dysfunction is noted consistently as a contributor to the outcomes of AKI, and estrogen alters mitochondrial bioenergetics, perhaps via estrogen receptors that may be present in mitochondria. The primacy of mitochondrial function in sex-defined susceptibility will be confirmed in this proposal by examining a novel mouse model, developed at our institution, of mitochondrial-nuclear exchange (MNX) (Aim 1). These mice have an exchange between two strains of mice such that the MNX mice have nuclear characteristics of one strain of mice and the mitochondrial characteristics of another strain of mice. Our preliminary data demonstrate that the parental strains of the MNX mice have different sex-based profiles in susceptibility to AKI allowing for the investigation of the influence of these organelles in an injury model. A second modulation of mitochondrial function will be examined with thermoneutrality, the ambient temperature at which no additional mitochondrial shunting to heat generation is required to maintain core body temperature. Standard vivarium temperatures are typically at ~22-23C (TS), while thermoneutral temperatures for rodents is ~30C (TT). Thermoneutrality alters sex-differences in other organ systems, but has not been studied in AKI and will be examined in these studies (Aim 2). Examination of changes in mitochondrial function with administration of estrogen or testosterone to modulate susceptibility to AKI have not investigated long-term hormone administration. Long-term administration of hormones, particularly cross-sex administration reflecting the status of transgender individuals, has been minimally studied, and not at all in the kidney (Aim 3). The integrated overall hypothesis is that mitochondrial bioenergetics and dynamics alters susceptibility to AKI in a sex-specific manner. In establishing how sex differences are modulated in these different paradigms, these studies will provide the baseline understanding needed to better define “female AKI” and determine nuanced differences that may be exploited in interventions.
急性肾损伤(阿基)困扰着大量住院患者,特别是那些危重患者。 伊利诺伊州由于在临床和动物模型中均观察到对女性阿基的保护作用,因此更好地阐明 这种保护的潜在生物学可能是必要的,以提供新的,有效的干预, 阿基的女性和男性。为了支持基于性别的阿基易感性,我们已经证明雌性小鼠 与男性相比,接受顺铂诱导的阿基(CP)的患者保留了肾功能, 严重的阿基。明确了女性对肾损伤的抵抗机制, 潜在的阐明独特的病理机制,并代表了我们的知识的关键差距。 线粒体功能障碍一直被认为是阿基结局的一个因素,雌激素改变了AKI的预后。 线粒体生物能量学,可能通过雌激素受体,可能存在于线粒体。至上 线粒体功能的性别定义的易感性将被证实在这个建议,通过检查一个新的 小鼠模型,在我们的机构开发的髓核交换(MNX)(目的1)。这些小鼠具有 两种小鼠品系之间的交换,使得MNX小鼠具有一种小鼠品系的细胞核特征, 小鼠和另一种小鼠的线粒体特征。我们的初步数据表明, MNX小鼠的亲本品系在对阿基的易感性方面具有不同的基于性别的特征, 研究这些细胞器在损伤模型中的影响。线粒体的第二种调节 功能将用热中性进行检查,在该环境温度下,没有额外的线粒体 需要分流到热量产生以维持核心体温。标准的动物园温度是 通常为~22-23 ℃(TS),而啮齿动物的热中性温度为~30 ℃(TT)。热中性改变 其他器官系统中的性别差异,但尚未在阿基中进行研究,并将在这些研究中进行检查 (Aim 2)。雌激素或睾酮对线粒体功能的影响 调节对阿基的易感性尚未研究长期激素施用。长期行政管理 激素,特别是反映变性人地位的跨性别给药, 研究最少,在肾脏中根本没有研究(目标3)。综合的总体假设是, 生物能量学和动力学以性别特异性方式改变对阿基的易感性。在确定性如何 差异在这些不同的范例中得到调制,这些研究将提供基线理解 需要更好地定义“女性阿基”,并确定在干预措施中可能利用的细微差别。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LISA M CURTIS其他文献

LISA M CURTIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LISA M CURTIS', 18)}}的其他基金

Developing Future Leaders in Nephrology
培养肾脏病学的未来领导者
  • 批准号:
    10318283
  • 财政年份:
    2021
  • 资助金额:
    $ 22.28万
  • 项目类别:
Cellular repair in acute kidney injury
急性肾损伤的细胞修复
  • 批准号:
    8392099
  • 财政年份:
    2011
  • 资助金额:
    $ 22.28万
  • 项目类别:
Cellular repair in acute kidney injury
急性肾损伤的细胞修复
  • 批准号:
    8241653
  • 财政年份:
    2011
  • 资助金额:
    $ 22.28万
  • 项目类别:
Cellular repair in acute kidney injury
急性肾损伤的细胞修复
  • 批准号:
    8598070
  • 财政年份:
    2011
  • 资助金额:
    $ 22.28万
  • 项目类别:
Enrichment and Training Program
丰富和培训计划
  • 批准号:
    10456262
  • 财政年份:
    2008
  • 资助金额:
    $ 22.28万
  • 项目类别:
Enrichment and Training Program
丰富和培训计划
  • 批准号:
    10252041
  • 财政年份:
    2008
  • 资助金额:
    $ 22.28万
  • 项目类别:
Enrichment and Training Program
丰富和培训计划
  • 批准号:
    9752536
  • 财政年份:
  • 资助金额:
    $ 22.28万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.28万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了